Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Intense general malaise/feeling of being sick with significant interference in activity; Mild pain at the injection site that did not interfere with activity/Moderate tenderness at the injection site (tenderness with movement); Mild swelling at the injection site; Severe fatigue with significant interference in activity; Intense muscle pain that significantly interfered with the activity.; Joint pain with some interference in activity; Headache that did not interfere with the activity; This spontaneous case was reported by a non-health professional and describes the occurrence of MALAISE (Intense general malaise/feeling of being sick with significant interference in activity), VACCINATION SITE PAIN (Mild pain at the injection site that did not interfere with activity/Moderate tenderness at the injection site (tenderness with movement)), VACCINATION SITE SWELLING (Mild swelling at the injection site), FATIGUE (Severe fatigue with significant interference in activity) and MYALGIA (Intense muscle pain that significantly interfered with the activity.) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In December 2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In December 2023, the patient experienced MALAISE (Intense general malaise/feeling of being sick with significant interference in activity), VACCINATION SITE PAIN (Mild pain at the injection site that did not interfere with activity/Moderate tenderness at the injection site (tenderness with movement)), VACCINATION SITE SWELLING (Mild swelling at the injection site), FATIGUE (Severe fatigue with significant interference in activity), MYALGIA (Intense muscle pain that significantly interfered with the activity.), ARTHRALGIA (Joint pain with some interference in activity) and HEADACHE (Headache that did not interfere with the activity). At the time of the report, MALAISE (Intense general malaise/feeling of being sick with significant interference in activity), VACCINATION SITE PAIN (Mild pain at the injection site that did not interfere with activity/Moderate tenderness at the injection site (tenderness with movement)), VACCINATION SITE SWELLING (Mild swelling at the injection site), FATIGUE (Severe fatigue with significant interference in activity), MYALGIA (Intense muscle pain that significantly interfered with the activity.), ARTHRALGIA (Joint pain with some interference in activity) and HEADACHE (Headache that did not interfere with the activity) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.       The Database Subject ID was reported as 5472040. The Health Authority Subject ID was reported as 78896-18940.  Concomitant medications were not reported.  Patient had experienced malaise, vaccination site pain, vaccination site swelling, fatigue, myalgia, arthralgia, headache anytime during the 2days after your COVID-19 vaccination, which occurred on Thursday, Dec 21, 2023 and Friday, Dec 22, 2023.  No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2024-756099 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-756099:Patient no 32